<!doctype html><html lang=en-us><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=generator content="Source Themes Academic 4.5.0"><meta name=author content="Nicholas Brazeau"><meta name=description content="Background: The infection fatality ratio (IFR) is a key statistic for estimating the burden of coronavirus disease 2019 (COVID-19) and has been continuously debated throughout the COVID-19 pandemic. The age-specific IFR can be quantified using antibody surveys to estimate total infections, but requires consideration of delay-distributions from time from infection to seroconversion, time to death, and time to seroreversion (i.e. antibody waning) alongside serologic test sensitivity and specificity. Previous IFR estimates have not fully propagated uncertainty or accounted for these potential biases, particularly seroreversion. Methods: We built a Bayesian statistical model that incorporates these factors and applied this model to simulated data and 10 serologic studies from different countries. Results: We demonstrate that seroreversion becomes a crucial factor as time accrues but is less important during first-wave, short-term dynamics. We additionally show that disaggregating surveys by regions with higher versus lower disease burden can inform serologic test specificity estimates. The overall IFR in each setting was estimated at 0.49-2.53%. Conclusion: We developed a robust statistical framework to account for full uncertainties in the parameters determining IFR. We provide code for others to apply these methods to further datasets and future epidemics."><link rel=alternate hreflang=en-us href=https://nicholasbrazeau.com/publication/brazeau-estimating-2022/><meta name=theme-color content="#2962ff"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin=anonymous><link rel=stylesheet href=https://use.fontawesome.com/releases/v5.6.0/css/all.css integrity=sha384-aOkxzJ5uQz7WBObEZcHvV5JvRW3TUc2rNPA7pe3AwnsUohiw1Vj2Rgx2KSOkF5+h crossorigin=anonymous><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin=anonymous><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/styles/darcula.min.css crossorigin=anonymous title=hl-light><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/styles/darcula.min.css crossorigin=anonymous title=hl-dark disabled><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Montserrat:400,700%7CRoboto:400,400italic,700%7CRoboto+Mono&display=swap"><link rel=stylesheet href=/css/academic.min.0129a70d91b556bfeee60a2761ebcab2.css><link rel=stylesheet href=/css/academic.396336b07aadc4bd6613abc2da9c9b8c.css><link rel=manifest href=/index.webmanifest><link rel=icon type=image/png href=/img/icon-32.png><link rel=apple-touch-icon type=image/png href=/img/icon-192.png><link rel=canonical href=https://nicholasbrazeau.com/publication/brazeau-estimating-2022/><meta property="twitter:card" content="summary_large_image"><meta property="twitter:site" content="@NFBrazeau"><meta property="twitter:creator" content="@NFBrazeau"><meta property="og:site_name" content="Nick Brazeau"><meta property="og:url" content="https://nicholasbrazeau.com/publication/brazeau-estimating-2022/"><meta property="og:title" content="Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling | Nick Brazeau"><meta property="og:description" content="Background: The infection fatality ratio (IFR) is a key statistic for estimating the burden of coronavirus disease 2019 (COVID-19) and has been continuously debated throughout the COVID-19 pandemic. The age-specific IFR can be quantified using antibody surveys to estimate total infections, but requires consideration of delay-distributions from time from infection to seroconversion, time to death, and time to seroreversion (i.e. antibody waning) alongside serologic test sensitivity and specificity. Previous IFR estimates have not fully propagated uncertainty or accounted for these potential biases, particularly seroreversion. Methods: We built a Bayesian statistical model that incorporates these factors and applied this model to simulated data and 10 serologic studies from different countries. Results: We demonstrate that seroreversion becomes a crucial factor as time accrues but is less important during first-wave, short-term dynamics. We additionally show that disaggregating surveys by regions with higher versus lower disease burden can inform serologic test specificity estimates. The overall IFR in each setting was estimated at 0.49-2.53%. Conclusion: We developed a robust statistical framework to account for full uncertainties in the parameters determining IFR. We provide code for others to apply these methods to further datasets and future epidemics."><meta property="og:image" content="https://nicholasbrazeau.com/img/headers/tree.jpg"><meta property="twitter:image" content="https://nicholasbrazeau.com/img/headers/tree.jpg"><meta property="og:locale" content="en-us"><meta property="article:published_time" content="2022-07-30T19:35:34+00:00"><meta property="article:modified_time" content="2022-07-30T15:35:34-04:00"><script type=application/ld+json>{"@context":"https://schema.org","@type":"Article","mainEntityOfPage":{"@type":"WebPage","@id":"https://nicholasbrazeau.com/publication/brazeau-estimating-2022/"},"headline":"Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling","datePublished":"2022-07-30T19:35:34Z","dateModified":"2022-07-30T15:35:34-04:00","author":{"@type":"Person","name":"Nicholas F. Brazeau"},"publisher":{"@type":"Organization","name":"Nick Brazeau","logo":{"@type":"ImageObject","url":"https://nicholasbrazeau.com/img/icon-512.png"}},"description":"Background: The infection fatality ratio (IFR) is a key statistic for estimating the burden of coronavirus disease 2019 (COVID-19) and has been continuously debated throughout the COVID-19 pandemic. The age-specific IFR can be quantified using antibody surveys to estimate total infections, but requires consideration of delay-distributions from time from infection to seroconversion, time to death, and time to seroreversion (i.e. antibody waning) alongside serologic test sensitivity and specificity. Previous IFR estimates have not fully propagated uncertainty or accounted for these potential biases, particularly seroreversion. Methods: We built a Bayesian statistical model that incorporates these factors and applied this model to simulated data and 10 serologic studies from different countries. Results: We demonstrate that seroreversion becomes a crucial factor as time accrues but is less important during first-wave, short-term dynamics. We additionally show that disaggregating surveys by regions with higher versus lower disease burden can inform serologic test specificity estimates. The overall IFR in each setting was estimated at 0.49-2.53%. Conclusion: We developed a robust statistical framework to account for full uncertainties in the parameters determining IFR. We provide code for others to apply these methods to further datasets and future epidemics."}</script><title>Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling | Nick Brazeau</title></head><body id=top data-spy=scroll data-offset=70 data-target=#TableOfContents><aside class=search-results id=search><div class=container><section class=search-header><div class="row no-gutters justify-content-between mb-3"><div class=col-6><h1>Search</h1></div><div class="col-6 col-search-close"><a class=js-search href=#><i class="fas fa-times-circle text-muted" aria-hidden=true></i></a></div></div><div id=search-box><input name=q id=search-query placeholder=Search... autocapitalize=off autocomplete=off autocorrect=off spellcheck=false type=search></div></section><section class=section-search-results><div id=search-hits></div></section></div></aside><nav class="navbar navbar-light fixed-top navbar-expand-lg py-0 compensate-for-scrollbar" id=navbar-main><div class=container><a class=navbar-brand href=/>Nick Brazeau</a>
<button type=button class=navbar-toggler data-toggle=collapse data-target=#navbar aria-controls=navbar aria-expanded=false aria-label="Toggle navigation">
<span><i class="fas fa-bars"></i></span></button><div class="collapse navbar-collapse" id=navbar><ul class="navbar-nav ml-auto"><li class=nav-item><a class=nav-link href=/about><span>About</span></a></li><li class=nav-item><a class=nav-link href=/post><span>Blog</span></a></li><li class=nav-item><a class=nav-link href=/projects><span>Research</span></a></li><li class=nav-item><a class=nav-link href=/pubs><span>Products</span></a></li><li class=nav-item><a class=nav-link href=/service><span>Service</span></a></li><li class=nav-item><a class=nav-link href=/consulting><span>Consulting</span></a></li><li class=nav-item><a class=nav-link href=/files/cv.pdf><span>CV</span></a></li><li class=nav-item><a class="nav-link js-search" href=#><i class="fas fa-search" aria-hidden=true></i></a></li></ul></div></div></nav><article class=article><div class="article-container pt-3"><h1>Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling</h1><div class=article-metadata><div><span><a href=/authors/nicholas-f.-brazeau/>Nicholas F. Brazeau</a></span>, <span><a href=/authors/robert-verity/>Robert Verity</a></span>, <span><a href=/authors/sara-jenks/>Sara Jenks</a></span>, <span><a href=/authors/han-fu/>Han Fu</a></span>, <span><a href=/authors/charles-whittaker/>Charles Whittaker</a></span>, <span><a href=/authors/peter-winskill/>Peter Winskill</a></span>, <span><a href=/authors/ilaria-dorigatti/>Ilaria Dorigatti</a></span>, <span><a href=/authors/patrick-g.-t.-walker/>Patrick G. T. Walker</a></span>, <span><a href=/authors/steven-riley/>Steven Riley</a></span>, <span><a href=/authors/ricardo-p.-schnekenberg/>Ricardo P. Schnekenberg</a></span>, <span><a href=/authors/henrique-hoeltgebaum/>Henrique Hoeltgebaum</a></span>, <span><a href=/authors/thomas-a.-mellan/>Thomas A. Mellan</a></span>, <span><a href=/authors/swapnil-mishra/>Swapnil Mishra</a></span>, <span><a href=/authors/h.-juliette-t.-unwin/>H. Juliette T. Unwin</a></span>, <span><a href=/authors/oliver-j.-watson/>Oliver J. Watson</a></span>, <span><a href=/authors/zulma-m.-cucunuba/>Zulma M. Cucunubá</a></span>, <span><a href=/authors/marc-baguelin/>Marc Baguelin</a></span>, <span><a href=/authors/lilith-whittles/>Lilith Whittles</a></span>, <span><a href=/authors/samir-bhatt/>Samir Bhatt</a></span>, <span><a href=/authors/azra-c.-ghani/>Azra C. Ghani</a></span>, <span><a href=/authors/neil-m.-ferguson/>Neil M. Ferguson</a></span>, <span><a href=/authors/lucy-c.-okell/>Lucy C. Okell</a></span></div><span class=article-date>January 2022</span></div><div class="btn-links mb-3"><button type=button class="btn btn-outline-primary my-1 mr-1 js-cite-modal" data-filename=/publication/brazeau-estimating-2022/cite.bib>
Cite</button>
<a class="btn btn-outline-primary my-1 mr-1" href=https://doi.org/10.1038/s43856-022-00106-7 target=_blank rel=noopener>DOI</a></div></div><div class=article-container><div class=article-style></div><div class=article-tags><a class="badge badge-light" href=/tags/computational-biology-and-bioinformatics/>Computational biology and bioinformatics</a>
<a class="badge badge-light" href=/tags/respiratory-tract-diseases/>Respiratory tract diseases</a></div><div class=share-box aria-hidden=true><ul class=share><li><a href="https://twitter.com/intent/tweet?url=https://nicholasbrazeau.com/publication/brazeau-estimating-2022/&text=Estimating%20the%20COVID-19%20infection%20fatality%20ratio%20accounting%20for%20seroreversion%20using%20statistical%20modelling" target=_blank rel=noopener class=share-btn-twitter><i class="fab fa-twitter"></i></a></li><li><a href="https://www.facebook.com/sharer.php?u=https://nicholasbrazeau.com/publication/brazeau-estimating-2022/&t=Estimating%20the%20COVID-19%20infection%20fatality%20ratio%20accounting%20for%20seroreversion%20using%20statistical%20modelling" target=_blank rel=noopener class=share-btn-facebook><i class="fab fa-facebook"></i></a></li><li><a href="mailto:?subject=Estimating%20the%20COVID-19%20infection%20fatality%20ratio%20accounting%20for%20seroreversion%20using%20statistical%20modelling&body=https://nicholasbrazeau.com/publication/brazeau-estimating-2022/" target=_blank rel=noopener class=share-btn-email><i class="fas fa-envelope"></i></a></li><li><a href="https://www.linkedin.com/shareArticle?url=https://nicholasbrazeau.com/publication/brazeau-estimating-2022/&title=Estimating%20the%20COVID-19%20infection%20fatality%20ratio%20accounting%20for%20seroreversion%20using%20statistical%20modelling" target=_blank rel=noopener class=share-btn-linkedin><i class="fab fa-linkedin-in"></i></a></li><li><a href="https://web.whatsapp.com/send?text=Estimating%20the%20COVID-19%20infection%20fatality%20ratio%20accounting%20for%20seroreversion%20using%20statistical%20modelling%20https://nicholasbrazeau.com/publication/brazeau-estimating-2022/" target=_blank rel=noopener class=share-btn-whatsapp><i class="fab fa-whatsapp"></i></a></li><li><a href="https://service.weibo.com/share/share.php?url=https://nicholasbrazeau.com/publication/brazeau-estimating-2022/&title=Estimating%20the%20COVID-19%20infection%20fatality%20ratio%20accounting%20for%20seroreversion%20using%20statistical%20modelling" target=_blank rel=noopener class=share-btn-weibo><i class="fab fa-weibo"></i></a></li></ul></div><div class="media author-card content-widget-hr"><div class=media-body><h5 class=card-title><a href=/authors/nicholas-f.-brazeau/></a></h5><ul class=network-icon aria-hidden=true></ul></div></div></div></article><script src=/js/mathjax-config.js></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/highlight.min.js integrity="sha256-aYTdUrn6Ow1DDgh5JTc3aDGnnju48y/1c8s1dgkYPQ8=" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/languages/r.min.js></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.4/MathJax.js?config=TeX-AMS_CHTML-full" integrity="sha256-GhM+5JHb6QUzOQPXSJLEWP7R73CbkisjzK5Eyij4U9w=" crossorigin=anonymous async></script>
<script>hljs.initHighlightingOnLoad()</script><script>const search_config={indexURI:"/index.json",minLength:1,threshold:.3},i18n={no_results:"No results found",placeholder:"Search...",results:"results found"},content_type={post:"Posts",project:"Projects",publication:"Publications",talk:"Talks"}</script><script id=search-hit-fuse-template type=text/x-template>
      <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
      </div>
    </script><script src=https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin=anonymous></script>
<script src=https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin=anonymous></script>
<script src=/js/academic.min.01f68d44d80310e669a1731b68a35481.js></script><div class=container><footer class=site-footer><p class=powered-by>© 2022 Nicholas Brazeau &#183;
<a href=https://github.com/nickbrazeau/nickbrazeau.github.io target=_blank rel=noopener><i class="fas fa-code-branch" style=color:#0072b2></i></a> &#183;
<span class=float-right aria-hidden=true><a href=# id=back_to_top><span class=button_icon><i class="fas fa-chevron-up fa-2x"></i></span></a></span></p></footer></div><div id=modal class="modal fade" role=dialog><div class=modal-dialog><div class=modal-content><div class=modal-header><h5 class=modal-title>Cite</h5><button type=button class=close data-dismiss=modal aria-label=Close>
<span aria-hidden=true>&#215;</span></button></div><div class=modal-body><pre><code class="tex hljs"></code></pre></div><div class=modal-footer><a class="btn btn-outline-primary my-1 js-copy-cite" href=# target=_blank><i class="fas fa-copy"></i> Copy</a>
<a class="btn btn-outline-primary my-1 js-download-cite" href=# target=_blank><i class="fas fa-download"></i> Download</a><div id=modal-error></div></div></div></div></div></body></html>